Herskovic, A., Russell, W., et al. (2012). Esophageal carcinoma: advances in treatment results for locally advanced disease. Annals Of Oncology, 23(5), 1095–1103. https://doi.org/10.1093/annonc/mdr602

Article  CAS  PubMed  Google Scholar 

Ajani, J. A., D’Amico, T. A., et al. (2011). Esophageal and esophagogastric junction cancers: clinical practice guidelines in oncology. Journal Of The National Comprehensive Cancer Network, 9(8), 830–887. https://doi.org/10.6004/jnccn.2011.0075

Article  PubMed  Google Scholar 

Housman, G., Byler, S., et al. (2014). Drug resistance in cancer: an overview. Cancers (Basel), 6(3), 1769–1792. https://doi.org/10.3390/cancers6031769

Article  PubMed  PubMed Central  Google Scholar 

Guo, Y., Bao, Y., et al. (2018). Identification of key pathways and genes in esophageal cancer using bioinformatics analysis. Oncol Lett, 16(4), 3790–3800. https://doi.org/10.3892/ol.2018.9184

Article  CAS  Google Scholar 

Carneiro, B. A., El-Deiry, W. S., et al. (2020). Targeted therapy in cancer: new advances and challenges. Nature Reviews. Clinical Oncology, 17(9), 535–554. https://doi.org/10.1038/s41571-020-0377-9

Article  Google Scholar 

Krook, M. A., Reeser, J. W., et al. (2021). Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance. British Journal Of Cancer, 124, 880–892. https://doi.org/10.1038/s41416-020-01157-0

Article  CAS  PubMed  Google Scholar 

Trueb, B., Taeschler, S., et al. (2010). Role of FGFRL1 and its domains in cancer. Cellular Signalling, 22(8), 1183–1192. https://doi.org/10.1016/j.cellsig.2010.03.018

Article  CAS  Google Scholar 

Trueb, B., Zhuang, L., et al. (2012). The FGFRL1 receptor: a review of its structure, signaling, and function. Cellular And Molecular Life Sciences, 69(6), 1029–1039. https://doi.org/10.1007/s00018-011-0867-8

Article  Google Scholar 

Zhuang, L., Trueb, B., et al. (2010). Genomic and functional studies on FGFRL1. Journal Of Biological Chemistry, 285(6), 3803–3813. https://doi.org/10.1074/jbc.M109.054502

Article  Google Scholar 

Silva, B., Lombard, A., et al. (2013). Interaction of FGFRL1 with SHP1 and its effect on ERK1/2 signaling. Oncogene, 32(21), 2605–2612. https://doi.org/10.1038/onc.2012.292

Article  CAS  Google Scholar 

Min, X., Song, F., et al. (2018). FGFR4 promotes chemoresistance by regulating glucose metabolism in breast cancer. Oncogenesis, 7, 22. https://doi.org/10.1038/s41389-018-0035-4

Article  Google Scholar 

Lee, S. H., Kim, H., et al. (2017). FGFRL1 in ovarian cancer: regulation of Hedgehog signaling. Molecular Cancer Research, 15(7), 1016–1027. https://doi.org/10.1158/1541-7786.MCR-16-0480

Article  CAS  Google Scholar 

Wang, L., Wang, Z., et al. (2018). FGFRL1 and the MAPK pathway in cancer. Cellular Signalling, 50, 22–29. https://doi.org/10.1016/j.cellsig.2018.06.001

Article  CAS  Google Scholar 

Trueb, B., Taeschler, S., et al. (2006). Expression of FGFRL1 during embryonic development. International Journal Of Molecular Medicine, 17(4), 617–620. https://www.spandidos-publications.com/ijmm/17/4/617

CAS  PubMed  Google Scholar 

Baertschi, A. J., Zhuang, L., et al. (2007). Mice with a targeted disruption of Fgfrl1 die at birth due to alterations in the diaphragm. Febs Journal, 274(24), 6241–6253. https://doi.org/10.1111/j.1742-4658.2007.06143.x

Article  CAS  PubMed  Google Scholar 

Chen, R., Li, D., et al. (2020). FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K/Akt pathway via ENO1. Journal Of Cellular And Molecular Medicine, 24(3), 2024–2035. https://doi.org/10.1111/jcmm.14763

Article  CAS  Google Scholar 

Pandey, P., Suyal, G., et al. (2023). NGS-based profiling identifies miRNAs and pathways dysregulated in cisplatin-resistant esophageal cancer cells. Functional And Integrative Genomics, 23(2), 111. https://doi.org/10.1007/s10142-023-01041-z

Article  CAS  PubMed  Google Scholar 

Katoh, M., et al. (2008). FGFR2 signaling regulates Notch signaling through Hes1 expression in gastric cancer. International Journal Of Oncology, 33(6), 1223–1229. PMID:19020727.

Google Scholar 

Armstrong, E., Timmis, J., et al. (2021). FGF signaling regulates Notch signaling to control left-right asymmetry in zebrafish. Development Biology, 473, 13–23. https://doi.org/10.1016/j.ydbio.2020.12.003

Article  CAS  Google Scholar 

Trueb, B., et al. (2011). Fibroblast growth factor receptor-like 1 (FGFRL1): the black sheep in the FGFR family. Cytokine & Growth Factor Reviews, 22(2), 203–214. https://doi.org/10.1016/j.cytogfr.2011.04.004

Article  Google Scholar 

Sleeman, M., Fraser, J., et al. (2001). Identification of a new fibroblast growth factor receptor, FGFR5. Gene, 271(2), 171–182. https://doi.org/10.1016/S0378-1119(01)00473-4

Article  CAS  PubMed  Google Scholar 

Silva, E. A., Yu, C., et al. (2012). FGFRL1 promotes ERK1/2 signaling and regulates cell proliferation. Journal Of Biological Chemistry, 287(30), 25206–25215. https://doi.org/10.1074/jbc.M112.355016

Article  CAS  Google Scholar 

Cui, Y., Yao, H., et al. (2019). Downregulation of FGFRL1 suppresses proliferation and migration of ovarian cancer cells via the Hedgehog signaling pathway. Biochemical And Biophysical Research Communications, 516(3), 977–982. https://doi.org/10.1016/j.bbrc.2019.06.127

Article  CAS  Google Scholar 

Trueb, B., et al. (2006). Fibroblast growth factor receptor-like 1 interacts with FGFs and modulates development. International Journal Of Molecular Medicine, 17(4), 617–620.

CAS  PubMed  Google Scholar 

Chen, J., Yin, J., et al. (2020). MiR-210 promotes esophageal squamous cell carcinoma progression by targeting FGFRL1. Oncology Reports, 43(3), 897–908. https://doi.org/10.3892/or.2020.7483

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wiedemann, M., Trueb, B., et al. (2000). The fibroblast growth factor receptor-like protein is a novel FGF binding protein that inhibits FGF signaling in Xenopus embryos. Journal Of Biological Chemistry, 275(30), 21970–21975. https://doi.org/10.1074/jbc.275.30.21970

Article  Google Scholar 

Shi, Q., Xue, C., et al. (2024). Notch signaling pathway in cancer: from mechanistic insights to targeted therapies. Signal Transduct Target Ther, 9, 128. https://doi.org/10.1038/s41392-024-01828-x

Article  PubMed  PubMed Central  Google Scholar 

Bazzoni, R., Bentivegna, A., et al. (2016). Context-dependent roles of Notch signaling in tumor progression and therapy resistance. Biomed Research International, 2016, 4280904. https://doi.org/10.1155/2016/4280904

Article  Google Scholar 

Meng, R. D., Shelton, C. C., et al. (2009). Gamma-secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Research, 69(2), 573–582. https://doi.org/10.1158/0008-5472.CAN-08-3010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, Z., Li, Y., et al. (2006). Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Molecular Cancer Therapeutics, 5(3), 483–493. https://doi.org/10.1158/1535-7163.MCT-05-0360

Article  CAS  PubMed  Google Scholar 

Sun, L., Ke, J., et al. (2017). HES1 promotes colorectal cancer cell resistance to 5-FU by inducing EMT and ABC transporter proteins. Journal Of Cancer, 8(14), 2802–2808. https://doi.org/10.7150/jca.19142

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee, J., Lee, J., et al. (2020). Association of Jagged1 expression with malignancy and prognosis in human pancreatic cancer. Cell Oncol (Dordr), 43(5), 821–834. https://doi.org/10.1007/s13402-020-00527-3

Article  CAS  PubMed  PubMed Central